Two of the four studies primarily focusing on the dermatologic manifestations of MEN1(Table 1) reported patients with melanoma: 2/48 (4%) in an NIH study (15) and 1/9 (11%) in the small Spanish study (16). This evidence concerns the gene MEN1 and melanoma.